Genetics

Patient with dry eye disease using eye drops
#Eye #Genetics #Ocular diseases

New research uncovers genetic causes of sight loss 

Scientists have uncovered new genetic causes of sight loss, paving the way for a genetic diagnosis for thousands of people.  Researchers, analysing data from Genomics England’s National Genomic Research Library (NGRL), found five new genetic causes of retinitis pigmentosa (RP), an eye condition that causes gradual blindness. Read More

#News

T cells
#Genetics #Sonoma Biotherapeutics #T cell

SonomaBio receives $300,000 grant to develop T-cell therapies 

Biotechnology company Sonoma Biotherapeutics has received a $300,000 G-Rex Grant to expedite the production of gene-modified regulatory T-cell therapies.  The grant was awarded by gene therapy manufacturer ScaleReady, aiming to advance the state of cell and gene-modified cell therapy development.   SonomaBio will now expedite the development of a G-Rex-based manufacturing process to develop T-cell (Treg) therapies… Read More

#Business & Investment #News

#Antibody #Genetics

FairJourney Biologics appoints Dr Werner Lanthaler as CEO

Biotechnology company FairJourney Biologics has appointed Dr Werner Lanthaler as Chief Executive Officer (CEO), the company has announced.   Lanthaler has forged an extensive career in the biopharmaceutical industry, driving innovation, transformation and sustainable growth. Lanthaler served as CEO of Evotec SE for 15 years, where he… Read More

#News

Myeloma cells
#Genetics #Myeloma #Oncology #Personalised medicine #The Institute of Cancer Research

Personalised treatment needed for high-risk myeloma, say scientists

Offering genetic testing to patients with myeloma would help doctors spot those with the most aggressive forms of the disease so that their cancer can be targeted more effectively, say scientists.  With effective treatment, more than half of myeloma patients will survive their disease for five years… Read More

#Cancer Research #Editor's Choice #News

Neurons in the brain
#Centogene #Drug targets #Genetics #Neuroscience #Parkinson's

15% of Parkinson’s cases linked to genetic factors, study says 

Centogene has announced data from its Rostock International Parkinson’s Disease (ROPAD) Study revealing the genetic factors and prevalence of Parkinson’s disease (PD).   The findings from the study indicate that approximately 15% of PD-related cases are tied to genetic variants, with the majority being linked to LRRK2 and… Read More

#News

#Biopharma #Cell line development #Cell lines #FDA #Genetic diseases #Genetics #R&D

New podcast: Challenges and tactics for drug development

This is the latest episode of the free DDW narrated podcast, “Challenges and tactics for transformative drug development”. It covers two articles written for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “Balancing speed and quality in CLD for faster drug development”, and… Read More

#News

Touchlight exterior view London
#Biopharmaceuticals #DNA #Genetics #Plasmid DNA

New London facility exceeds global plasmid DNA demand 

Touchlight, a company providing DNA services and manufacturing enzymes, has completed the redevelopment and expansion of its UK manufacturing facility in London, UK.   The expanded facility’s manufacturing capacity has tripled and is now capable of producing more than 8kg a year. This exceeds the current, but growing,… Read More

#News

Female medical researcher
#Genetics #Genetics / genomics #Icahn School of Medicine #Neuroscience #Psychiatry #Schizophrenia

Researchers identify genes that may increase schizophrenia risk

Researchers have identified two previously unknown genes linked to schizophrenia and newly implicated a third gene as carrying risk for both schizophrenia and autism. Led by the Icahn School of Medicine at Mount Sinai, the multi-centre study further demonstrated that the schizophrenia risk conferred by these… Read More

#News

Researcher pipetting samples in microplate
#Drug delivery #Funding #Genetics #Genetics / genomics #Investment #Start-ups

Start-up aims to advance transformative genetic medicines

Aera Therapeutics has launched with a vision to “unlock the potential of genetic medicines across a wide range of modalities and therapeutic areas”.   The company’s delivery platform is based on research conducted in the laboratory of scientific founder Feng Zhang and aims to address the limitations of… Read More

#News #Start-up Zone

#AstraZeneca #Biobanking #Covid-19 #Genetics #Genomics #Public health #Research

Podcast: Is genomic data the new frontier in drug discovery?

This is the latest episode of the free narrated DDW podcast, “Is genomic data the new frontier in drug discovery?” It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “Genomics boosts understanding of Covid-19 severity and susceptibility” and “… Read More

#News

#Chronic Fatigue Syndrome #Genetics #Long Covid #Myalgic Encephalomyelitis

Study reveals first genetic links in ME and Chronic Fatigue Syndrome

A new study has provided the first detailed genetic insights into the pathophysiological mechanisms underpinning Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).   This is the first time that replicable genetic findings have been reported in over 30 years of study into the disease, potentially offering new approaches for better… Read More

#News

A laboratory mouse
#Animal models #Animal testing #Genetic editing #Genetics #Phenotyping

NIH renews knockout mouse project for 3rd time

The University of California, Davis, has received over $12 million from the National Institutes of Health for the third and final five-year phase of the Knockout Mouse Phenotyping Project (KOMP2). ‘Knockout’ mice are bred in a laboratory with specific genes silenced or ‘knocked out’. They have been valuable tools for… Read More

#News

#Cancer #Genetics #Oncology

Could elephant genes hold the key to avoiding cancers?

Scientists modelling the cancer-suppressing p53 gene identify how the 20 different molecules unique to elephants get activated for increased sensitivity and response against carcinogenic conditions – with implications for cancer treatments in humans. Scientists from seven research institutions including the University of Oxford and the University of Edinburgh have used… Read More

#Cancer Research #Editor's Choice #News

#Covid-19 #Drug discovery #Genetics

Biotechs partner to understand genetics of long Covid   

A partnership between life sciences companies PrecisionLife and Sano Genetics aims to drive insights into the genetics of long Covid and potentially identify new treatments.    The companies will analyse Sano Genetics’ data of 3,000 adults suffering from long Covid symptoms using PrecisionLife’s combinatorial analytics platform… Read More

#Covid-19 #News

#FDA #Genetic diseases #Genetics #R&D

Sitting down with BridgeBio Pharma

Listen to this article on the DDW Podcast: Michael Henderson, MD, Chief Business Officer of BridgeBio Pharma, tells Lu Rahman about the company’s pursuit of transformative medicines to treat genetic diseases. BridgeBio’s mission is to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and… Read More

#Exclusive Content #Opinion

#Biopharma #Clinical trial #Covid-19 #Genetics #Vaccines

This week in drug discovery (18-22 April)  

News round-up by DDW’s Reece Armstrong for 18-22 April    Covid-19, the link between ageing and genetic mutations, alongside funding opportunities for drug developers are some of the themes of this week’s news round-up.   1: Researchers shed light on ageing in new… Read More

#News